# RNN 1st Gen Model Patterson Companies, Inc. Medical & hospital equipment

Stock predictor AI models:
64.29% successful of 42 deals
$ 31.80 Last close price
at 18-oct-2021


Model's trade recommendations 2.53% Return for period

-0.17% Annual return

$2.21B Market Cap

β 1.15  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 2.53%
52wk return -7.38%
52wk Range
Sortino ratio -0.01
Sharpe ratio -0.00
Norm. RMSE 1.24%
Downside risk 8.05%
Volatility 0.00%
  • 1.04 (4.46%) Div (Yield)
  • HOLD Analysts consensus recommendation

Patterson Companies, Inc. is a value-added distributor serving the dental and animal health markets. As a market leading dental and animal health company, they supply technology, products and equipment, as well as marketing, support and logistics services. Patterson Veterinary and Animal Health International are leading distributors of consumable supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to both the companion pet and production animal markets.

Industry sector: Medical

Sector classification: Medical & hospital equipment

Deep Learning based analysis and prediction model for Patterson Companies, Inc. (PDCO) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for PDCO model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for PDCO.

Model is being retrained on a daily basis.

Float 94M
P/E 11.26
Shares Outstanding 95M
% Held by Insiders 0.46%
% Held by Institutions 94.26%
EPS (last reported FY) $2.34
EPS (last reported Q) $0.43
EPS, estimated (last reported Q) $0.51
Total revenues $6 B
Net income $0 B